 incid new primari cancer adjuv tamoxifen therapi radiotherapi earli breast cancer incid new primari cancer postmenopaus patient surgic treatment primari breast cancer patient low risk recurr treatment high-risk patient group first group postop radiotherapi second group radiotherapi tamoxifen dose mg week median observ time year comparison number new cancer gener popul number new cancer group due high number cancer contralater breast colorect cancer high-risk group cumul risk nonlymphat leukemia patient postop radiotherapi cancer incid high-risk tamoxifen-tr group rel high-risk group tamoxifen signific protect effect tamoxifen opposit breast rate ratio breast cancer tendenc risk endometri cancer rate ratio confid interv care follow-up women tamoxifen necessari potenti cancer-suppress cancer-promot effect drug